⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
ANGPTL8–AKT2–mTOR Adipose Senescence Axis
Current understanding
ANGPTL8, a secreted hepatokine/adipokine, has been nominated as an endocrine driver of adipose-tissue senescence and systemic aging via an AKT2–mTOR–S6K signaling axis, with Angptl8 knockout reported to extend mouse lifespan and circulating ANGPTL8 associated with human biological age and mortality [animal-model + human-observational, single-report]. The pathway ties nutrient-sensing (mTOR) directly to a fat-derived senescence trigger, but no human interventional data exist and translation is unproven.
Evidence log
- 2026-06-01 — Adipose tissue as a systemic modulator of brain aging: mechanistic links between metabolism, inflammation and neurodegeneration.: cross-connection with adipose-brain-aging-axis: Frames ANGPTL8-driven adipose senescence as one molecular substrate within the broader adipose-derived signaling axis implicated in brain aging. (novelty: 3)
- 2026-04-13 — The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.: cross-connection with sarcopenia-glam-metabolic-inflammatory-axis: The ANGPTL8–AKT2–mTOR adipose senescence axis instantiates the adipose-to-mTOR arm of the GLAM framework, tying a specific adipokine to the shared AMPK/mTOR module. (novelty: 3)
- 2026-08-05 — The Immunometabolic Bridge: Targeting Metainflammation to Prevent the Transition from Obesity to Cardiovascular Disease.: cross-connection with inflammaging: Review positions adipose dysfunction as the origin of the metainflammation-to-CVD bridge, converging on the same adipose-secretory drivers (ANGPTL8-type endocrine signals) implicated in adipose senescence and systemic inflammatory tone. (novelty: 3)
- 2026-08-01 — Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies.: cross-connection with vascular-aging: Review links adipose-tissue senescence and its endocrine output (SASP, adipokines) to cardiac senescence via an adipose–heart crosstalk arm, consistent with ANGPTL8-type adipose-secreted drivers of systemic aging. (novelty: 3)
- 2026-07-13 — Enhancing insulin sensitivity by reducing adipocyte senescence using uPAR-targeted nanoparticles in high-fat-diet-induced obese mice.: cross-connection with cellular-senescence: Both findings converge on adipose tissue as a senescent-cell reservoir driving systemic metabolic aging: ANGPTL8–AKT2–mTOR as an endocrine trigger upstream, uPAR-targeted D+Q nanoparticles as a downstream clearance strategy — nominates adipocyte senescence as a discrete druggable node for insulin sensitivity. (novelty: 3)
- 2026-07-23 — Exercise attenuates atherosclerosis by inhibiting eWAT aging via targeting SIRT1/pyruvate carboxylase pathway.: cross-connection with sirt1-sirtuins: Both nominate adipose tissue as a senescence-secretory hub upstream of systemic aging phenotypes: ANGPTL8–AKT2–mTOR drives adipose senescence, while the SIRT1/pyruvate carboxylase axis is engaged by exercise to suppress epididymal WAT senescence — convergent adipose-senescence node with opposing pharmacologic vs. behavioral entry points. (novelty: 3)
- 2026-08-01 — An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline.: cross-connection with aging-omic-biomarkers: Circulating ANGPTL8 reported to correlate with human biological-age clocks and mortality, positioning it as a candidate protein biomarker of aging alongside existing omic clocks. (novelty: 4)
Open questions
Related
Contributing findings
An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline.
01-aug-2026
novelty 4
per-area 4
introduces